Related references
Note: Only part of the references are listed.How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies
Hann-Chorng Kuo
TZU CHI MEDICAL JOURNAL (2022)
Effects of different urodynamic characteristics on therapeutic outcomes of overactive bladder medication in a real-life clinical practice
Hsiu-Jen Wang et al.
TZU CHI MEDICAL JOURNAL (2022)
The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis
Sofia Tsiapakidou et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2021)
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2020)
Effect of amniotic fluid stem cell transplantation on the recovery of bladder dysfunction in spinal cord-injured rats
Ching-Chung Liang et al.
SCIENTIFIC REPORTS (2020)
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis
Con Kelleher et al.
EUROPEAN UROLOGY (2018)
Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis
Hsiao-Ling Chen et al.
WORLD JOURNAL OF UROLOGY (2018)
Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: An immunohistochemical study
Ana Coelho et al.
NEUROUROLOGY AND URODYNAMICS (2017)
Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients
Yoon Seok Suh et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2017)
Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
Yoon Seok Suh et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2017)
Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study
Carlo Vecchioli Scaldazza et al.
UROLOGIA INTERNATIONALIS (2016)
NGF and HB-EGF: Potential Biomarkers that Reflect the Effects of Fesoterodine in Patients with Overactive Bladder Syndrome
Soo Rim Kim et al.
YONSEI MEDICAL JOURNAL (2015)
Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a 3-adrenoceptor agonist, in patients with overactive bladder in Asia
Hann-Chorng Kuo et al.
NEUROUROLOGY AND URODYNAMICS (2015)
An Overactive Bladder Symptom and Health-Related Quality of Life Short-Form: Validation of the OAB-q SF
Karin S. Coyne et al.
NEUROUROLOGY AND URODYNAMICS (2015)
Retubularization of the ileocystoplasty patch for conversion into an ileal conduit
Peter A. Massaro et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2013)
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2013)
Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European-Australian Phase 3 Trial
Vik Khullar et al.
EUROPEAN UROLOGY (2013)
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
V. W. Nitti et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
A Functional Analysis of the Influence of β3-adrenoceptors on the Rat Micturition Cycle
Prajni Sadananda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Effects of Mirabegron, a Novel β3-Adrenoceptor Agonist, on Primary Bladder Afferent Activity and Bladder Microcontractions in Rats Compared With the Effects of Oxybutynin
Naoki Aizawa et al.
EUROPEAN UROLOGY (2012)
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction
Debra E. Irwin et al.
BJU INTERNATIONAL (2011)
Urinary Nerve Growth Factor Levels in Overactive Bladder Syndrome and Lower Urinary Tract Disorders
Hsin-Tzu Liu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2010)
Effects of CL316,243, a beta(3)-Adrenoceptor Agonist, and Intravesical Prostaglandin E-2 on the Primary Bladder Afferent Activity of the Rat
Naoki Aizawa et al.
NEUROUROLOGY AND URODYNAMICS (2010)
Symptom severity and patient perceptions in overactive bladder: how are they related?
Yukio Homma et al.
BJU INTERNATIONAL (2009)
Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder
Hsin-Tzu Liu et al.
BJU INTERNATIONAL (2009)
Catecholamines Relax Detrusor through beta(2)-Adrenoceptors in Mouse and beta(3)-Adrenoceptors in Man
Melinda Wuest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Prospective pharmacologic therapies for the overactive bladder
Karl-Erik Andersson
THERAPEUTIC ADVANCES IN UROLOGY (2009)
Effects of the β3-adrenergic receptor agonist disodium 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]1,3-benzodioxole-2,2-dicarboxylate (CL-316243) on bladder micturition reflex in spontaneously hypertensive rats
Lisa A. Leon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Expression and functional role of β-adrenoceptors in the human urinary bladder urothelium
Atsushi Otsuka et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis
Man-Jung Hung et al.
JOURNAL OF UROLOGY (2006)
Estimation of the Youden index and its associated cutoff point
R Fluss et al.
BIOMETRICAL JOURNAL (2005)
Drug therapy - Management of overactive bladder
JG Ouslander
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antimuscarinics for treatment of overactive bladder
KE Andersson
LANCET NEUROLOGY (2004)
Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women
GD Chen et al.
NEUROUROLOGY AND URODYNAMICS (2003)
Prevalence and burden of overactive bladder in the United States
WF Stewart et al.
WORLD JOURNAL OF UROLOGY (2002)
The standardisation of terminology of lower urinary tract function: Report from the of the International Standardisation Sub-Committee Continence Society
P Abrams et al.
NEUROUROLOGY AND URODYNAMICS (2002)
How widespread are the symptoms of an overactive bladder and how are they managed?: A population-based prevalence study
I Milsom et al.
BJU INTERNATIONAL (2001)
Share Paper
